Non-heme induction of heme oxygenase-1 does not alter cellular iron metabolism

被引:44
|
作者
Sheftel, Alex D.
Kim, Sangwon F.
Ponka, Prem
机构
[1] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada
[2] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada
[3] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA
关键词
D O I
10.1074/jbc.M700240200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The catabolism of heme is carried out by members of the heme oxygenase ( HO) family. The products of heme catabolism by HO-1 are ferrous iron, biliverdin ( subsequently converted to bilirubin), and carbon monoxide. In addition to its function in the recycling of hemoglobin iron, this microsomal enzyme has been shown to protect cells in various stress models. Implicit in the reports of HO-1 cytoprotection to date are its effects on the cellular handling of heme/iron. However, the limited amount of uncommitted heme in non-erythroid cells brings to question the source of substrate for this enzyme in non-hemolytic circumstances. In the present study, HO-1 was induced by either sodium arsenite ( reactive oxygen species producer) or hemin or overexpressed in the murine macrophage-like cell line, RAW 264.7. Both of the inducers elicited an increase in active HO-1; however, only hemin exposure caused an increase in the synthesis rate of the iron storage protein, ferritin. This effect of hemin was the direct result of the liberation of iron from heme by HO. Cells stably overexpressing HO-1, although protected from oxidative stress, did not display elevated basal ferritin synthesis. However, these cells did exhibit an increase in ferritin synthesis, compared with untransfected controls, in response to hemin treatment, suggesting that heme levels, and not HO-1, limit cellular heme catabolism. Our results suggest that the protection of cells from oxidative insult afforded by HO-1 is not due to the catabolism of significant amounts of cellular heme as thought previously.
引用
收藏
页码:10480 / 10486
页数:7
相关论文
共 50 条
  • [41] The archaeal non-heme iron-containing Sulfur Oxygenase Reductase
    Ferreira, P.
    Fernandes, P. A.
    Ramos, M. J.
    COORDINATION CHEMISTRY REVIEWS, 2022, 455
  • [42] THE ROLE OF HEME OXYGENASE-1 INDUCTION AND INTRACELLULAR METABOLISM OF BILIRUBIN IN RESPONSE TO OXIDATIVE STRESS
    Zelenka, Jaroslav
    Muchova, Lucie
    Vitek, Libor
    HEPATOLOGY, 2008, 48 (04) : 1124A - 1124A
  • [43] Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides
    Ham, D
    Schipper, HM
    CELLULAR AND MOLECULAR BIOLOGY, 2000, 46 (03) : 587 - 596
  • [44] Heme Oxygenase-1, Ferroportin and SAMHD1 Induction By Heme Inhibits HIV-1
    Kumari, Namita
    Ammosova, Tatiana
    Nekhai, Sergei
    BLOOD, 2015, 126 (23)
  • [45] CloR, a bifunctional non-heme iron oxygenase involved in clorobiocin biosynthesis
    Pojer, F
    Kahlich, R
    Kammerer, B
    Li, SM
    Heide, L
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (33) : 30661 - 30668
  • [46] Expression of heme oxygenase isozyme mRNAs in the human brain and induction of heme oxygenase-1 by nitric oxide donors
    Takahashi, K
    Hara, E
    Suzuki, H
    Sasano, H
    Shibahara, S
    JOURNAL OF NEUROCHEMISTRY, 1996, 67 (02) : 482 - 489
  • [47] Pharmacologic Induction of Heme Oxygenase-1: It Is Time to Take It Seriously
    Li Volti, Giovanni
    Murabito, Paolo
    CRITICAL CARE MEDICINE, 2014, 42 (08) : 1967 - 1968
  • [48] Induction of heme oxygenase-1 in the donor reduces graft immunogenicity
    Martins, PNA
    Kessler, H
    Jurisch, A
    Reutzel-Selke, A
    Kramer, J
    Pascher, A
    Pratschke, J
    Neuhaus, P
    Volk, HD
    Tullius, SG
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (01) : 384 - 386
  • [49] Induction of heme oxygenase-1 mRNA by TMH-ferrocene
    Lambrecht, RW
    Gildemeister, OS
    Pepe, JA
    Bonkovsky, HL
    HEPATOLOGY, 1996, 23 (01) : H296 - H296
  • [50] Induction of heme oxygenase-1 in the porcine lung after birth
    Stanford, SJ
    Hislop, AA
    Haworth, SG
    Mitchell, JA
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U25 - U25